No Data
Insider Sale: Chief Medical Officer of $ADAP (ADAP) Sells 5,584 Shares
Adaptimmune Announces U.S. FDA Breakthrough Therapy Designation Granted to Letetresgene Autoleucel (Lete-cel) for Treatment of Myxoid/Round Cell Liposarcoma (MRCLS)
European Equities Traded in the US as American Depositary Move Slightly Lower in Thursday Trading
Adaptimmune Says CFO, Other C-Suite Officer to Step Down
Adaptimmune: Focusing Increasing Proportion of Corporate Functions in U.S. >ADAP
Adaptimmune: Co-Founder, Chief Business & Strategy Officer Helen Tayton-Martin to Step Down on March 31 >ADAP
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
